Abstract CT058: Ripretinib (DCC-2618) pharmacokinetics (PK) in a Phase I study in patients with gastrointestinal stromal tumors (GIST) and other advanced malignancies: A retrospective evaluation of the PK effects of proton pump inhibitors (PPIs)
2019 ◽
2019 ◽
Vol 25
(24)
◽
pp. 7287-7293
◽
2006 ◽
Vol 12
(4)
◽
pp. 1251-1259
◽
2003 ◽
Vol 51
(6)
◽
pp. 459-464
◽